Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Am J Cardiol. 2011 Apr 1;107(7):986-9. doi: 10.1016/j.amjcard.2010.11.022. Epub 2011 Jan 20.
We sought to determine the differential prognosis of patients with a normal single-photon emission computed tomographic (SPECT) perfusion study by type of stress modality. Even with a normal SPECT perfusion study, patients selected for adenosine stress have a worse survival than those selected for exercise stress. In patients who are able, low-level treadmill exercise is commonly performed during adenosine infusion ("walking" adenosine). The adjusted differential prognosis of patients performing walking adenosine is unknown. Our historical cohort underwent adenosine or treadmill stress with SPECT imaging during 2003 and 2004. Adenosine studies were classified as walking or adenosine only (no low-level exercise). Patients with an abnormal single-photon emission computed tomogram or missing demographic information were excluded. All-cause mortality was determined through July 2008. In total 3,479 patients were included, of which 1,451 (41.7%) were stressed with adenosine only, 201 (5.8%) with walking adenosine, and 1,827 (52.5%) with treadmill exercise. Over an average of 4.3 ± 1.0 years of follow-up, 307 (8.8%) died. Mortality was greatest for adenosine only, intermediate for walking adenosine, and least for exercise (p <0.001 by log-rank test), even after accounting for covariates (adjusted hazard ratio for walking adenosine 0.57, p = 0.044). In conclusion, patients with a normal SPECT perfusion scan who are able to undergo an adenosine protocol in conjunction with exercise have an intermediate prognosis between those who cannot perform low-level exercise and patients able to undergo full treadmill exercise. This differential survival remains significant after adjustment, perhaps because of differences in baseline functional capacity.
我们试图通过压力方式的类型来确定单光子发射计算机断层扫描(SPECT)灌注研究正常患者的不同预后。即使 SPECT 灌注研究正常,选择腺苷压力的患者的生存预后也比选择运动压力的患者差。在能够进行的患者中,在腺苷输注期间通常会进行低水平跑步机运动(“行走”腺苷)。进行行走腺苷的患者的调整后的不同预后尚不清楚。我们的历史队列在 2003 年和 2004 年期间接受了腺苷或跑步机压力与 SPECT 成像。将腺苷研究分为行走腺苷或仅腺苷(无低水平运动)。排除了单光子发射计算机断层图异常或缺少人口统计学信息的患者。通过 2008 年 7 月确定所有原因死亡率。共有 3479 例患者入选,其中 1451 例(41.7%)仅用腺苷压力,201 例(5.8%)用行走腺苷,1827 例(52.5%)用跑步机运动。在平均 4.3 ± 1.0 年的随访中,有 307 例(8.8%)死亡。仅用腺苷的死亡率最高,行走腺苷的死亡率居中,运动的死亡率最低(对数秩检验,p <0.001),即使在考虑了协变量后也是如此(行走腺苷的调整后危险比为 0.57,p = 0.044)。总之,能够进行腺苷方案并结合运动的 SPECT 灌注扫描正常的患者的预后处于无法进行低水平运动的患者和能够进行全跑步机运动的患者之间。在调整后,这种差异生存仍然具有统计学意义,这可能是由于基线功能能力的差异。